+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Acute ischemic stroke (AIS) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Acute ischemic stroke (AIS) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 224 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
KPL-716 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KPL-716 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 234 Pages
  • Global
From
Asia Pacific Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 125 Pages
  • Asia Pacific
From
Europe Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 126 Pages
  • Europe
From
LAMEA Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 126 Pages
  • Middle East, Africa
From
North America Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 116 Pages
  • North America
From
Immunomodulators - Global Strategic Business Report - Product Thumbnail Image

Immunomodulators - Global Strategic Business Report

  • Report
  • September 2025
  • 280 Pages
  • Global
From
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 628 Pages
  • Global
From
Long-Acting Drug Delivery Technologies and Services Market Industry Trends and Global Forecasts to 2035, by Compatible Dosage Form, Principle, Strategy, Type of Molecule Delivered, Type of Material Used, and Key Geographical Regions - Product Thumbnail Image

Long-Acting Drug Delivery Technologies and Services Market Industry Trends and Global Forecasts to 2035, by Compatible Dosage Form, Principle, Strategy, Type of Molecule Delivered, Type of Material Used, and Key Geographical Regions

  • Report
  • March 2025
  • 291 Pages
  • Global
From
Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends - Product Thumbnail Image

Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends

  • Report
  • August 2023
  • 122 Pages
  • Global
From
Hodgkins Lymphoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Hodgkins Lymphoma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 127 Pages
  • Global
From
HPV Associated Disorders Market Report 2025 - Product Thumbnail Image

HPV Associated Disorders Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Generic Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Generic Pharmaceuticals Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 193 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 1000 Pages
  • Global
From
Leveraging Personalised Content to Effectively Engage with HCPs - Product Thumbnail Image

Leveraging Personalised Content to Effectively Engage with HCPs

  • Report
  • March 2023
  • Global
From
Biosimilars Market 2025-2029 - Product Thumbnail Image

Biosimilars Market 2025-2029

  • Report
  • February 2025
  • 219 Pages
  • Global
From
Loading Indicator